Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2959-2026

TD Navio Midi Speech Generating Device Recall

TD Navio Midi Speech Generating Device Model/Catalog Number: 1000798

FDA recall Class II

Ongoing

FDA lists this Class II recall for TD Navio Midi Speech Generating Device. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2959-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 8, 2026
FDA report date
Aug 26, 2026
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Device Design

What is being recalled?

TD Navio Midi Speech Generating Device Model/Catalog Number: 1000798

Affected model & UDI checker

Search the exact identifiers published for Z-2959-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
1000798TD Navio Midi Speech Generating DeviceCheck source noticeNot specified
FDA code information

UDI-DI 073400747602056 Serial Numbers TDNM1-240628000004 through TDNM1-260617070001. Corrected/future production is differentiated by new serialization from TDNM1-260617070001 onward (production batch 20260615, improved design).

View the original FDA recall notice

Why was this product recalled?

Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and gas venting within the device enclosure.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Tobii Dynavox Llc take?

On July 8, 2026, the firm notified customers by emailing letters titled "URGENT: MEDICAL DEVICE RECALL NOTICE." Customers were informed that Tobii Dynavox would provide a repair authorization number (RA#), prepaid shipping label, inspection, repair, and return shipping for the affected device. The repair will include modifications intended to improve battery stability within the device. Customers were provided with ways to contact the company to obtain a repair authorization number. Customers were informed that it is safe to continue using the device as intended while waiting for the repair, as long as there are no signs of overheating, swelling, unusual odor, smoke, deformation, or battery abnormality. If any of these conditions are observed, discontinue use immediately and contact Tobbi Dynavox.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology